Analytical Services for mAb, ADC, and Protein Drugs
Analytical and bioanalytical methods are crucial in the development of monoclonal antibodies (mAb), antibody-drug conjugates (ADC), and other protein drugs. From early-stage discovery and preclinical testing to clinical trials and CMC (Chemistry, Manufacturing, and Controls) support, robust analytical methodologies ensure the safety, efficacy, and quality of therapeutics. Their role is indispensable in advancing innovative therapies and bringing life-saving treatments to patients.
Analytical Services for mAb, ADC, and Protein Drugs
Our Expertise
We are dedicated to accelerating your biologic drug development process and ensuring the safety, efficacy, and quality of your therapeutic candidates. Our expertise spans genomics, proteomics, microbial analysis, and immunoassays, supporting a wide range of biologics, including monoclonal antibodies (mAbs), Antibody-drug conjugates, protein drugs, and other therapeutic proteins. Explore our detailed service offerings below, categorized into preclinical studies, clinical studies, and Chemistry, Manufacturing, and Controls (CMC)
Analytical Support Through All Stages of Product Lifecycle
Phase
Technologies
Applications
Development
- Clone selection/screening
- Genetic stability testing
- Growth kinetics analysis
- mAb /Protein Expression and Characterization
Preclinical Studies
- Immunogenicity studies
- Biomarker analysis
- In vitro efficacy studies
- Cytokine release assays
Clinical Studies
- Clinical PK/PD studies
- Patient stratification
- Immunogenicity testing
- Biomarker validation
- Companion diagnostics development
- Cytokine release assays
